|
|
|
|
Molecular Pharmacology, Vol 20, 435-441, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics
1 Division of Clinical Pharmacology, Departments of Medicine and Pharmacology and the Cardiovascular Research Institute,
University of California School of Medicine, San Francisco, California 94143
Adenylate cyclase in H21a, a recently isolated S49 mutant cell line, fails to synthesize cyclic AMP in response to hormones, cholera toxin, guanine nucleotides, and NaF. H21a membranes contain Mr = 42,000 and 52,000 peptide subunits of the guanine nucleotide-binding regulatory component (N protein) of adenylate cyclase. These peptides are ADP-ribosylated by cholera toxin in H21a, as in wild-type S49. Nonetheless, extracts of H21a membranes do not complement the functional defect of N-deficient cyc- S49 membranes in vitro [M. R. Salomon and H. R. Bourne, Mol. Pharmacol. 19:109-116 (1981)]. We asked whether N in H21a can perform functions observed in wild-type S49 but absent or deficient in cyc- and in another S49 mutant, unc. The N lesion in unc is thought to prevent interaction with receptors and allow normal interaction with the catalytic unit. Like wild-type, but unlike cyc- and unc, membranes of H21a contained beta-adrenergic receptors that exhibited high affinity for binding an agonist (isoproterenol) in the absence, but not in the presence, of GTP. In addition, exposure of H21a cells to isoproterenol for 16 hr caused an 85% decrease in density of beta-adrenergic receptors. Agonist-induced down-regulation of beta-adrenergic receptors occurred to a similar extent in wild-type, but not in unc. These results suggest that the N protein in H21a can interact with hormone receptors, but not with catalytic adenylate cyclase. Two-dimensional gel electrophoresis showed that the size and charge of the Mr = 42,000 and 52,000 cholera toxin substrates are similar in wild-type and H21a membranes. The H21a and unc lesions appear to affect the same protein, because extracts of each type of mutant membrane failed to complement the adenylate cyclase defect of the other in vitro.
Note:
ACKNOWLEDGMENT
We thank Naomi Walker for technical assistance.
This article has been cited by other articles:
![]() |
S. P. Sheikh, J.-P. Vilardarga, T. J. Baranski, O. Lichtarge, T. Iiri, E. C. Meng, R. A. Nissenson, and H. R. Bourne Similar Structures and Shared Switch Mechanisms of the beta 2-Adrenoceptor and the Parathyroid Hormone Receptor. Zn(II) BRIDGES BETWEEN HELICES III AND VI BLOCK ACTIVATION J. Biol. Chem., June 11, 1999; 274(24): 17033 - 17041. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Apanovitch, T. Iiri, T. Karasawa, H. R. Bourne, and H. G. Dohlman Second Site Suppressor Mutations of a GTPase-deficient G-Protein alpha -Subunit. SELECTIVE INHIBITION OF Gbeta gamma -MEDIATED SIGNALING J. Biol. Chem., October 30, 1998; 273(44): 28597 - 28602. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Grishina and C. H. Berlot Mutations at the Domain Interface of Gsalpha Impair Receptor-mediated Activation by Altering Receptor and Guanine Nucleotide Binding J. Biol. Chem., June 12, 1998; 273(24): 15053 - 15060. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iiri, Z. Farfel, and H. R. Bourne Conditional activation defect of a human Gsalpha mutant PNAS, May 27, 1997; 94(11): 5656 - 5661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Kurjan, J P Hirsch, and C Dietzel Mutations in the guanine nucleotide-binding domains of a yeast G alpha protein confer a constitutive or uninducible state to the pheromone response pathway. Genes & Dev., March 1, 1991; 5(3): 475 - 483. [Abstract] [PDF] |
||||
![]() |
H.R. Bourne, S.B. Masters, R.T. Miller, K.A. Sullivan, and W. Heideman Mutations Probe Structure and Function of G-protein {alpha} Chains Cold Spring Harb Symp Quant Biol, January 1, 1988; 53(0): 221 - 228. [Abstract] [PDF] |
||||